Zardi; Luciano

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zardi; Luciano.The latest application filed is for "compositions and methods for treatment of angiogenesis in pathological lesions".

Company Profile

0.11.10

Zardi; Luciano - Genoa IT
ZARDI; Luciano - Genova IT
Zardi; Luciano - Camogli IT
Zardi; Luciano - Recco IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibodies of the ED-B domain of fibronectin, their construction and uses Grant 9,096,670 - Neri , et al. August 4, 2	2015-08-04
Compositions And Methods For Treatment Of Angiogenesis In Pathological Lesions App 20140348784 - ZARDI; Luciano ; et al.	2014-11-27
Compositions and methods for treatment of angiogenesis in pathological lesions Grant 8,784,824 - Zardi , et al. July 22, 2	2014-07-22
Antibodies Of The Ed-b Domain Of Fibronectin, Their Construction And Uses App 20140134182 - NERI; Dario ; et al.	2014-05-15
Antibodies of the ED-B domain of fibronectin, their construction and uses Grant 8,703,143 - Neri , et al. April 22, 2	2014-04-22
Compositions and methods for treatment of angiogenesis in pathological lesions Grant 8,623,373 - Zardi , et al. January 7, 2	2014-01-07
Process for engineering polyvalent, polyspecific fusion proteins using uteroglobin as skeleton and so obtained products. App 20130189735 - Zardi; Luciano	2013-07-25
Selective targeting of tumor vasculature using antibody molecules Grant 8,491,906 - Borsi , et al. July 23, 2	2013-07-23
Compositions And Methods For Treatment Of Angiogenesis In Pathological Lesions App 20100316602 - Zardi; Luciano ; et al.	2010-12-16
Selective Targeting Of Tumor Vasculature Using Radiolabelled Antibody Molecules App 20090214423 - Borsi; Laura ; et al.	2009-08-27
Antibodies Of The Ed-b Domain Of Fibronectin, Their Construction And Uses App 20080274099 - Neri; Dario ; et al.	2008-11-06
Antibodies to the ED-B domain of fibronectin, their construction and uses Grant 7,273,924 - Neri , et al. September 25, 2	2007-09-25
Tenascin-C isoform as marker for neoplasias Grant 7,109,301 - Zardi September 19, 2	2006-09-19
Selective targeting of tumor vasculature using antibody molecules App 20060057146 - Borsi; Laura ; et al.	2006-03-16
Selective targeting of tumor vasculature using radiolabelled antibody molecules App 20050074401 - Borsi, Laura ; et al.	2005-04-07
Compositions and methods for treatment of angiogenesis in pathological lesions App 20040013640 - Zardi, Luciano ; et al.	2004-01-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.